Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 102 citing articles:

A Combined Proteomics and Metabolomics Profiling to Investigate the Genetic Heterogeneity of Autistic Children
Liming Shen, Huajie Zhang, Lin Jing, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3529-3545
Open Access | Times Cited: 18
Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease
Senthilkumar Preethy, Nobunao Ikewaki, Gary Levy, et al.
BMJ Open Gastroenterology (2022) Vol. 9, Iss. 1, pp. e000985-e000985
Open Access | Times Cited: 18
Urinary Untargeted Metabolic Profile Differentiates Children with Autism from Their Unaffected Siblings
Anna Maria Timperio, Federica Gevi, Francesca Cucinotta, et al.
Metabolites (2022) Vol. 12, Iss. 9, pp. 797-797
Open Access | Times Cited: 17
Fecal Microbiota Transplantation in Autism Spectrum Disorder
Youran Li, Yizhong Wang, Ting Zhang
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 2905-2915
Open Access | Times Cited: 17
Gut microbiota signature in children with autism spectrum disorder who suffered from chronic gastrointestinal symptoms
Hui Wang, Shu Liu, Liqing Xie, et al.
BMC Pediatrics (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Review of Elevated Para-Cresol in Autism and Possible Impact on Symptoms
Christina K. Flynn, James B. Adams, Rosa Krajmalnik‐Brown, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1513-1513
Open Access
Effects of gastrointestinal symptoms on the efficacy of washed microbiota transplantation in patients with autism
Dongxia Hu, Cheng‐Kai Lu, X.C. Si, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access
Limitations of genomics to predict and treat autism: a disorder born in the womb
Yehezkel Ben‐Ari, Étienne Danchin
Journal of Medical Genetics (2025), pp. jmg-110224
Closed Access
Gut microbiota and blood metabolites: unveiling their roles in hippocampal volume changes through Mendelian randomization and mediation analysis
Zhi Huang, Xia Du, Fangzhou Li, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Closed Access
Microbiota-based therapies as novel targets for autism spectrum disorder: A systematic review and meta-analysis
Lucas Hassib, Alexandre Kanashiro, João Francisco Cordeiro Pedrazzi, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111385-111385
Closed Access
Microbial modulation via cross-fostering prevents the effects of pervasive environmental stressors on microglia and social behavior, but not the dopamine system
Caroline J. Smith, Danielle N. Rendina, Marcy A. Kingsbury, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 6, pp. 2549-2562
Open Access | Times Cited: 9
Zebrafish (Danio rerio) as a translational model for neuro-immune interactions in the enteric nervous system in autism spectrum disorders
Audrey Inge Schytz Andersen‐Civil, Rajlakshmi Anjan Sawale, Gilles Vanwalleghem
Brain Behavior and Immunity (2023) Vol. 112, pp. 254-266
Open Access | Times Cited: 9
Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications
Enriqueta García-Gutiérrez, A. Kate O’Mahony, Reinaldo S. Dos Santos, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
More than just a number: the gut microbiota and brain function across the extremes of life
Nathan D. Nuzum, Clara Deady, Sarah Kittel‐Schneider, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Intestinal Metabolome for Diagnosing and Prognosing Autism Spectrum Disorder in Children: A Systematic Review
Andrés Suárez‐Jaramillo, Sara G. Cifuentes, Manuel E. Baldeón, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 213-213
Open Access
Interventions targeting the gut microbiota and their possible effect on gastrointestinal and neurobehavioral symptoms in autism spectrum disorder
Evelyn Takyi, Khemlal Nirmalkar, James B. Adams, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Microbiome First Medicine in Health and Safety
Rodney R. Dietert
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1099-1099
Open Access | Times Cited: 19
Autonomic Nervous System Neuroanatomical Alterations Could Provoke and Maintain Gastrointestinal Dysbiosis in Autism Spectrum Disorder (ASD): A Novel Microbiome–Host Interaction Mechanistic Hypothesis
Athanasios Beopoulos, Manuel Géa, Alessio Fasano, et al.
Nutrients (2021) Vol. 14, Iss. 1, pp. 65-65
Open Access | Times Cited: 19
Comparative plasma metabolomic analysis to identify biomarkers for lead-induced cognitive impairment
Yuqin Wang, Yuan Nong, Xing Zhang, et al.
Chemico-Biological Interactions (2022) Vol. 366, pp. 110143-110143
Closed Access | Times Cited: 14
A Diet Supplemented with Polyphenols, Prebiotics and Omega-3 Fatty Acids Modulates the Intestinal Microbiota and Improves the Profile of Metabolites Linked with Anxiety in Dogs
Eden Ephraim, Jeffrey A. Brockman, Dennis E. Jewell
Biology (2022) Vol. 11, Iss. 7, pp. 976-976
Open Access | Times Cited: 13
Early life gut microbiota: Consequences for health and opportunities for prevention
Shumin Wang, Jingjing Cui, Shilong Jiang, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 17, pp. 5793-5817
Closed Access | Times Cited: 13
The effect of probiotic, prebiotic and gut microbiota on ASD: A review and future perspectives
Nevin Şanlıer, Şule Kocabaş
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 15, pp. 2319-2330
Closed Access | Times Cited: 18
Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological Disorders
Matthew Wiefels, Emily Furar, Rebecca S. Eshraghi, et al.
Current Neuropharmacology (2022) Vol. 22, Iss. 1, pp. 123-139
Open Access | Times Cited: 12
Distinct metabolic profiles associated with autism spectrum disorder versus cancer in individuals with germline PTEN mutations
Lamis Yehia, Ying Ni, Tammy Sadler, et al.
npj Genomic Medicine (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 11
[Recent research on neurodevelopmental disorders in children].
Hongmin Zhu, Chunhui Yuan, Zhisheng Liu
PubMed (2023) Vol. 25, Iss. 1, pp. 91-97
Closed Access | Times Cited: 6

Scroll to top